108557002: Doxazosin mesilate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with adrenergic receptor antagonist mechanism of action (substance)\Alpha adrenergic receptor antagonist\Alpha-1 adrenergic receptor antagonist\Doxazosin mesilate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Alpha adrenergic receptor antagonist\Alpha-1 adrenergic receptor antagonist\Doxazosin mesilate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Vasodilator (substance)\Doxazosin mesilate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinazoline (substance)\Doxazosin mesilate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

173091019 Doxazosin mesylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2692000012 Doxazosin mesilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3726095019 Doxazosin mesilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

31081000188118 doxazosine mésilate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Doxazosin mesilate	Is a	Product containing doxazosin (medicinal product)	false	Inferred relationship	Some
Doxazosin mesilate	Is a	Doxazosin (substance)	false	Inferred relationship	Some
Doxazosin mesilate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha-1 adrenergic receptor antagonist (disposition)	true	Inferred relationship	Some
Doxazosin mesilate	Is a	Quinazoline (substance)	true	Inferred relationship	Some
Doxazosin mesilate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Doxazosin (substance)	true	Inferred relationship	Some
Doxazosin mesilate	Is a	Alpha-1 adrenergic receptor antagonist	true	Inferred relationship	Some
Doxazosin mesilate	Is a	Alpha adrenergic receptor antagonist	false	Inferred relationship	Some
Doxazosin mesilate	Is a	Autonomic agent (substance)	false	Inferred relationship	Some
Doxazosin mesilate	Is a	Vasodilator (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Doxazosin mesylate 1mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some
Doxazosin mesylate 2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some
Doxazosin mesylate 4mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some
Doxazosin mesylate 8mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some
Doxazosin (as doxazosin mesilate) 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some
Doxazosin (as doxazosin mesilate) 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some
Doxazosin (as doxazosin mesilate) 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some
Doxazosin (as doxazosin mesilate) 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some	1
Doxazosin (as doxazosin mesilate) 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some	1
Doxazosin (as doxazosin mesilate) 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Doxazosin mesilate	Inferred relationship	Some	1
Product containing precisely doxazosin (as doxazosin mesilate) 8 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Doxazosin mesilate	Inferred relationship	Some	1
Product containing precisely doxazosin (as doxazosin mesilate) 4 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Doxazosin mesilate	Inferred relationship	Some	1
Doxazosin (as doxazosin mesilate) 2 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Doxazosin mesilate	Inferred relationship	Some	1
Doxazosin (as doxazosin mesilate) 4 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Doxazosin mesilate	Inferred relationship	Some	1
Doxazosin (as doxazosin mesilate) 1 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Doxazosin mesilate	Inferred relationship	Some	1
Doxazosin (as doxazosin mesilate) 8 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Doxazosin mesilate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
173091019	Doxazosin mesylate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2692000012	Doxazosin mesilate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3726095019	Doxazosin mesilate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
31081000188118	doxazosine mésilate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module